thalidomide has been researched along with Entrapment Syndrome, Ulnar Nerve in 1 studies
Thalidomide: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.
thalidomide : A racemate comprising equimolar amounts of R- and S-thalidomide.
2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione : A dicarboximide that is isoindole-1,3(2H)-dione in which the hydrogen attached to the nitrogen is substituted by a 2,6-dioxopiperidin-3-yl group.
Excerpt | Relevance | Reference |
---|---|---|
"Thalidomide, a sedative popular in the 1950s and withdrawn from the market in the 1960s because of its teratogenic effects, has emerged again on the market in the last decade as an effective agent in the treatment of multiple myeloma." | 7.81 | [Thalidomide induced peripheral neuropathy in multiple myeloma patients]. ( Banach, M; Jurczyszyn, A; Skotnicki, A, 2015) |
"Thalidomide, a sedative popular in the 1950s and withdrawn from the market in the 1960s because of its teratogenic effects, has emerged again on the market in the last decade as an effective agent in the treatment of multiple myeloma." | 3.81 | [Thalidomide induced peripheral neuropathy in multiple myeloma patients]. ( Banach, M; Jurczyszyn, A; Skotnicki, A, 2015) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Banach, M | 1 |
Jurczyszyn, A | 1 |
Skotnicki, A | 1 |
1 other study available for thalidomide and Entrapment Syndrome, Ulnar Nerve
Article | Year |
---|---|
[Thalidomide induced peripheral neuropathy in multiple myeloma patients].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carpal Tunnel Syndrome; Female; Humans; Male; | 2015 |